Intravesical BCG administration in the guinea pig. A histomorphological study. 1988

A P van der Meijden, and W H de Jong, and P A Steerenberg, and H C Walvoort, and E C de Boer, and F M Debruyne, and E J Ruitenberg
Department of Urology, St. Radboud University Hospital, Nijmegen, The Netherlands.

Intravesical BCG administration is used as an adjuvant therapy after transurethral resection for superficial bladder cancer in man. The mechanisms of its antitumor activity are not known. The aim of this study was to characterize the histomorphological changes in various organs of the guinea pig after intravesical BCG administration. The BCG preparation used was BCG-RIVM, a Dutch BCG preparation. Instillations were performed in previously undamaged bladders weekly for 6 consecutive weeks and lasted 30 min or 1 h. Different doses were used ranging from 10(3) culturable particles (c.p.) to 5 x 10(7) c.p. of BCG. After 6 weeks, the animals were killed and postmortem examination was performed. The bladder wall, retroperitoneal lymph nodes, spleen, liver, lungs and distant lymph nodes were examined histologically. The BCG therapy, with a dose of 10(6) culturable particles and higher, induced an inflammatory reaction consisting of mononuclear infiltrates in the subepithelial tissue of the bladder wall. In approximately 50% of the animals investigated, the infiltrates were accompanied by non-caseating granulomatous lesions indicated by the presence of epithelioid cells. In general, the epithelial layer of the bladder showed no visible alterations. Similarly, a granulomatous inflammatory reaction was observed in the first retroperitoneal (iliac) lymph nodes draining the bladder. Granulomatous lesions were occasionally also present in liver and lung. In three of the 29 animals investigated, lesions were present both in liver and lungs, and in two of these three animals a granulomatous reaction was observed in the spleen and distant lymph nodes indicating a generalized inflammatory response induced by BCG.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D001745 Urinary Bladder Diseases Pathological processes of the URINARY BLADDER. Bladder Diseases,Bladder Disease,Urinary Bladder Disease
D005260 Female Females
D006099 Granuloma A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents. Granulomas
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A P van der Meijden, and W H de Jong, and P A Steerenberg, and H C Walvoort, and E C de Boer, and F M Debruyne, and E J Ruitenberg
June 1968, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
A P van der Meijden, and W H de Jong, and P A Steerenberg, and H C Walvoort, and E C de Boer, and F M Debruyne, and E J Ruitenberg
January 2002, Joint bone spine,
A P van der Meijden, and W H de Jong, and P A Steerenberg, and H C Walvoort, and E C de Boer, and F M Debruyne, and E J Ruitenberg
April 2000, European urology,
A P van der Meijden, and W H de Jong, and P A Steerenberg, and H C Walvoort, and E C de Boer, and F M Debruyne, and E J Ruitenberg
May 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A P van der Meijden, and W H de Jong, and P A Steerenberg, and H C Walvoort, and E C de Boer, and F M Debruyne, and E J Ruitenberg
February 1978, European journal of cancer,
A P van der Meijden, and W H de Jong, and P A Steerenberg, and H C Walvoort, and E C de Boer, and F M Debruyne, and E J Ruitenberg
January 1977, Developments in biological standardization,
A P van der Meijden, and W H de Jong, and P A Steerenberg, and H C Walvoort, and E C de Boer, and F M Debruyne, and E J Ruitenberg
October 1974, Cancer,
A P van der Meijden, and W H de Jong, and P A Steerenberg, and H C Walvoort, and E C de Boer, and F M Debruyne, and E J Ruitenberg
January 1974, Johns Hopkins medical journal. Supplement,
A P van der Meijden, and W H de Jong, and P A Steerenberg, and H C Walvoort, and E C de Boer, and F M Debruyne, and E J Ruitenberg
February 1979, Japanese journal of medical science & biology,
A P van der Meijden, and W H de Jong, and P A Steerenberg, and H C Walvoort, and E C de Boer, and F M Debruyne, and E J Ruitenberg
December 1989, British journal of urology,
Copied contents to your clipboard!